Investment firm KKR confirms the sale of LGC to major consortium
Date: 2019-11-23   Author: Pankaj Singh  Category: #news

Investment firm KKR confirms the sale of LGC to major consortium

The leading global investment firm KKR reportedly announced having sold off a pioneer in the Life Science Tools sector, LGC to Cinven and Astorg. However, the financial terms of the deal have not yet been disclosed by the parties.

For the uninitiated, LGC, headquartered in London, offers an overall range of measurement tools, proficiency testing schemes, specialty genomics reagents, and supply chain assurance standards manufactured by leading analytical and measurement science capabilities. Apparently, the company serves numerous customers across the world including human healthcare, food, agriculture, and environment.

Speaking on the matter, the CEO of LGC, Tim Robinson exclaimed that KKR’s ownership has led the company move further on its mission to offer Science for a safe and secure world. The company has expanded its capabilities in the fields of chemical reference standards, management system standard, clinical reference materials and control, and next-gen sequencing. He further added that the company since inception has accomplished robust organic growth supported by the investment in key sites across various region.

It has been claimed that LGC is delighted to be partnered with LGC for the upcoming years and is expecting to continue its investment in catering its services to the customers whilst supporting the development of the employees.

Meanwhile, Edouard Pillot, the Member and EMEA Head of Industries reportedly cited that the group has successfully identified LGC as a strong business partner offering significant growth prospects in the upcoming years. He, on behalf of the whole company, tends to see the LGC company reaching new levels of height in the near future with this new chapter of the unison with Cinven and Astorg.

Estimates claim that the Director in Healthcare Industry Team and Head of Europe for the Healthcare Strategic Growth Fund, Kugan Sathiyanandarajah has presented his views on the same stating that 2016 saw high potential for the growth of leading global life science tools platform across Standards and Genomics. This has allowed them to deploy an entire portfolio of KKR’s global platform and healthcare segment expertise to aid the company’s development and venture into new markets.
 

Source credit: https://www.businesswire.com/news/home/20191121005374/en/KKR-Agrees-Sale-LGC-Cinven-Astorg



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

High Voltage Cables Market 2020 By Industry Trends & Regional Forecast To 2025
Author: Rahul Varpe

Decresearch added a new report on global High Voltage Cables Market to its research database. The report focuses on global major leading players with information such as company profiles, growth, product segment, technology segment, end user segme...


Electric Submersible Pump Market 2019 By Industry Trends & Growth Forecast To 2025
Author: Rahul Varpe

Decresearch added a new report on global Electric Submersible Pump Market to its research database. The report focuses on global major leading players with information such as company profiles, growth, product segment, technology segment, end user...


Submarine Power Cable Market 2020 By Industry Trends & Regional Forecast To 2025
Author: Rahul Varpe

Decresearch added a new report on global Submarine Power Cable Market to its research database. The report focuses on global major leading players with information such as company profiles, growth, product segment, technology segment, end user seg...